EU member states will stockpile medicines and invest in new production of key drugs to prevent shortages and a repeat of the panic buying from overseas that occurred during the Covid-19 pandemic.
Legislators and governments agreed on a Critical Medicines Act on Tuesday that aims to end persistent scarcity of key drugs and reduce reliance on imports, although it is likely to increase prices.
“Patients should not have to worry about whether critical medicines such as antibiotics will be available at their pharmacy or hospital,” said Neophytos Charalambides, health minister of Cyprus, which holds the rotating EU presidency.
您已阅读22%（626字），剩余78%（2209字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。